Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Elliott

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
International Journal of Radiation Oncology, Biology, Physics|December 23, 2022
The Impact of Parent and Family Caregiver Roles Among Canadian Radiation OncologistsAisling Barry, Mary Elliott, Shaun Loewen, et al.
American Heart Journal|November 15, 2019
Getting to an ImprOved Understanding of Low-Density Lipoprotein-Cholesterol and Dyslipidemia Management (GOULD): Methods and baseline data of a registry of high cardiovascular risk patients in the United StatesChristopher P Cannon, James A de Lemos, Robert S Rosenson, et al.
Circulation|June 9, 2019
Use of Guideline-Recommended Risk Reduction Strategies Among Patients With Diabetes and Atherosclerotic Cardiovascular DiseaseSuzanne V Arnold, James A de Lemos, Robert S Rosenson, et al.
American Heart Journal|December 31, 2023
Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trialErin A Bohula, Nicholas A Marston, Andrea Ruzza, et al.
Journal of the American College of Cardiology|February 7, 2024
Long-Term Efficacy of Evolocumab in Patients With or Without Multivessel Coronary DiseaseDaniel J McClintick, Michelle L O'Donoghue, Gaetano M De Ferrari, et al.
Circulation|August 29, 2022
Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular DiseaseMichelle L O'Donoghue, Robert P Giugliano, Stephen D Wiviott, et al.
JAMA|April 4, 2016
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical TrialSteven E Nissen, Erik Stroes, Ricardo E Dent-Acosta, et al.
Nature Medicine|January 14, 2022
Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)Michael J Koren, Patrick Maurice Moriarty, Seth J Baum, et al.
Circulation|February 13, 2023
Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLEPrakriti Gaba, Michelle L O'Donoghue, Jeong-Gun Park, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
International Journal of Radiation Oncology, Biology, Physics|December 23, 2022
The Impact of Parent and Family Caregiver Roles Among Canadian Radiation OncologistsAisling Barry, Mary Elliott, Shaun Loewen, et al.
American Heart Journal|November 15, 2019
Getting to an ImprOved Understanding of Low-Density Lipoprotein-Cholesterol and Dyslipidemia Management (GOULD): Methods and baseline data of a registry of high cardiovascular risk patients in the United StatesChristopher P Cannon, James A de Lemos, Robert S Rosenson, et al.
Circulation|June 9, 2019
Use of Guideline-Recommended Risk Reduction Strategies Among Patients With Diabetes and Atherosclerotic Cardiovascular DiseaseSuzanne V Arnold, James A de Lemos, Robert S Rosenson, et al.
American Heart Journal|December 31, 2023
Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trialErin A Bohula, Nicholas A Marston, Andrea Ruzza, et al.
Journal of the American College of Cardiology|February 7, 2024
Long-Term Efficacy of Evolocumab in Patients With or Without Multivessel Coronary DiseaseDaniel J McClintick, Michelle L O'Donoghue, Gaetano M De Ferrari, et al.
Circulation|August 29, 2022
Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular DiseaseMichelle L O'Donoghue, Robert P Giugliano, Stephen D Wiviott, et al.
JAMA|April 4, 2016
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical TrialSteven E Nissen, Erik Stroes, Ricardo E Dent-Acosta, et al.
Nature Medicine|January 14, 2022
Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)Michael J Koren, Patrick Maurice Moriarty, Seth J Baum, et al.
Circulation|February 13, 2023
Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLEPrakriti Gaba, Michelle L O'Donoghue, Jeong-Gun Park, et al.
Pageof 3